These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10064012)

  • 1. The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations.
    Franco RF; Elion J; Tavella MH; Santos SE; Zago MA
    Thromb Haemost; 1999 Feb; 81(2):312-3. PubMed ID: 10064012
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of Factor V Leiden in three ethnic groups of patients with deep vein thrombosis in the Western Cape province of South Africa.
    Rubinstein R; Kolia F; Novitzky N
    Eur J Haematol; 2000 Jul; 65(1):78-9. PubMed ID: 10914945
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of Arg306 mutations of factor V gene.
    Liang R; Lee CK; Wat MS; Kwong YL; Lam CK; Liu HW
    Blood; 1998 Oct; 92(7):2599-600. PubMed ID: 9746807
    [No Abstract]   [Full Text] [Related]  

  • 4. A Thai patient with the mutation of Arg306 of FV gene identical to the Hong Kong but not to the Cambridge type.
    Hiyoshi M; Hashimoto S; Tagawa S; Arnutti P; Prayoonwiwat W; Tatsumi N
    Thromb Haemost; 1999 Nov; 82(5):1553-4. PubMed ID: 10595653
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in venous thrombotic disease.
    Franco RF; Maffei FH; Lourenço D; Morelli V; Thomazini IA; Piccinato CE; Tavella MH; Zago MA
    Br J Haematol; 1998 Dec; 103(3):888-90. PubMed ID: 9858251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Arg306 --> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese.
    Shen MC; Lin JS; Tsay W
    Thromb Haemost; 2001 Feb; 85(2):270-3. PubMed ID: 11246546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.
    Balogh I; Póka R; Losonczy G; Muszbek L
    Thromb Haemost; 1999 Nov; 82(5):1555-6. PubMed ID: 10595655
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of factor V Leiden mutation in non-European populations.
    Pepe G; Rickards O; Vanegas OC; Brunelli T; Gori AM; Giusti B; Attanasio M; Prisco D; Gensini GF; Abbate R
    Thromb Haemost; 1997 Feb; 77(2):329-31. PubMed ID: 9157591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor V Leiden and prothrombin 20210A mutations in indigenous Australians.
    Bennett JA; Palmer LJ; Musk AW; Erber WN
    Thromb Haemost; 2001 Dec; 86(6):1592-3. PubMed ID: 11776339
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
    Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How old is factor V Leiden mutation?
    Pawar AR; Shetty S; Ghosh K; Mohanty D
    Thromb Haemost; 2001 Dec; 86(6):1591-2. PubMed ID: 11776338
    [No Abstract]   [Full Text] [Related]  

  • 12. The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia.
    Bôžiková A; Gabriková D; Sovičová A; Behulová R; Mačeková S; Boroňová I; Petrejčíková E; Soták M; Bernasovská J; Bernasovský I
    J Thromb Thrombolysis; 2012 Oct; 34(3):406-9. PubMed ID: 22562116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of factor V Arg306--Thr and low factor V Arg306->Gly mutation prevalence in Thai blood donors.
    Chuansumrit A; Jarutwachirakul W; Sasanakul W; Rurgkhum S; Kadegasem P; Kitpoka P; Sirachainan N
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):450-2. PubMed ID: 15691154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma model.
    van der Neut Kolfschoten M; Dirven RJ; Tans G; Rosing J; Vos HL; Bertina RM
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):207-15. PubMed ID: 11943934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.
    Chegeni R; Kazemi B; Hajifathali A; Pourfathollah A; Lari GR
    Thromb Res; 2007; 119(2):189-93. PubMed ID: 16542711
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor V Arg2074Cys: a novel missense mutation in the C2 domain of factor V.
    Bossone A; D'Angelo F; Santacroce R; De Lucia D; Margaglione M
    Thromb Haemost; 2002 May; 87(5):923-4. PubMed ID: 12038802
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype.
    Okada H; Toyoda Y; Takagi A; Saito H; Kojima T; Yamazaki T
    Int J Hematol; 2010 Apr; 91(3):549-50. PubMed ID: 20300981
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of the factor V Leiden mutation in a nonselected black population.
    Pottinger P; Sigurdsson F; Berliner N
    Blood; 1996 Mar; 87(5):2091. PubMed ID: 8634464
    [No Abstract]   [Full Text] [Related]  

  • 20. Ser234Leu missense mutation in the A1 domain of factor V causing moderate factor V deficiency in a Chinese family.
    Jin PP; Wang XF; Ding QL; Fu QH; Cai XH; Shen LS; Wang HL
    Pathology; 2009; 41(6):566-71. PubMed ID: 19900106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.